Allogene Therapeutics ALLO Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's prepaid & other current?
- Allogene Therapeutics (ALLO) reported prepaid & other current of $6.41M in Q1 2026.
- How has Allogene Therapeutics's prepaid & other current changed year-over-year?
- Allogene Therapeutics's prepaid & other current decreased by 44.4% year-over-year, from $11.53M to $6.41M.
- What is the long-term trend for Allogene Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Allogene Therapeutics's prepaid & other current has grown at a -15.2% compound annual growth rate (CAGR), from $17.22M to $7.54M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.